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The Vespula allergen is a 37-kDa phospholipase A1 known as Ves
v 1.1 Ves v 5 (antigen 5) is a 23-kDa protein found in Vespula
venom.1 Recently, several studies reported the diagnostic sensi-
tivity of the novel recombinant Ves v 5 (rVes v 5) and rVes 1 aller-
gens in a routine clinical laboratory setting by analyzing a group of
Vespula venom-allergic patients.2,3 Although Ves v 5 is by far the
most important allergen in Vespula venom, including hornet
venom, some people are sensitized to only Ves v 1. Of note, neither
Ves v 5 nor Ves v 1 is found in honey bee venom. Recombinant ver-
sions of the Ves v 5 and rVes v 1 allergen components (rVes v 5 and
rVes v 1, respectively), which are both expressed in insect cells,
were developed in 2010 and 2011, respectively, for use in Immuno-
CAP solid-phase immunoglobulin (Ig)E assay (capsulated hydro-
philic carrier polymer (CAP)-ﬂuoro-enzyme immunoassay (FEIA);
Phadia, Uppsala, Sweden). In this study, we analyzed the sensitiza-
tion of speciﬁc (s)IgE-positive individuals who had experienced Hy-
menoptera stings to rVes v 1 and rVes v 5.
Subjects were 27 Japanese (21 men, 6 women; mean age,
61.9 ± 9.5 years; range, 39e81 years) who had experienced Hyme-
noptera stings and the subsequent systemic reaction and who had
visited Dokkyo Medical University between March and December
2013. Twenty volunteers (18 men, 2 women; mean age,
32.6 ± 4.5 years; range, 25e51 years) who had never experienced
a Hymenoptera sting were enrolled as controls. Severity of systemic
reactions was graded according to Mueller4 as follows: Grade 1e3
(mild), 17 subjects; and Grade 4 (severe), 10 subjects. The total
number of stings occurring in a period of no longer than 5 years
was classiﬁed as few (1e4 stings) in 20 subjects and many (5
stings) in 7. All the participants completed a medical examination
involving an interview with an allergist and underwent peripheral
blood tests. This study was approved by the Dokkyo Medical Uni-
versity Research Ethics Committee, and each participant provided
written informed consent prior to study enrollment.
The intervals between the last sting and peripheral blood collec-
tion differed among the subjects. Levels of serum sIgE against hor-
net venom, rVes v 1, and rVes v 5 were measured by Phadia (Tokyo,
Japan). Detection of sIgE by the CAP system using FEIA was
expressed in quantitative units (UA/ml) or as a traditional spectrum
of 7 semi-quantitative classes ranging from class 0 (<0.35 UA/ml) toPeer review under responsibility of Japanese Society of Allergology.
http://dx.doi.org/10.1016/j.alit.2014.08.008
1323-8930/Copyright © 2014, Japanese Society of Allergology. Production and hosting by Elsclass 6 (100 UA/ml). In this study, sIgE-positive results were
deﬁned as an sIgE level >0.35 UA/ml (i.e., class 1).
Data are presented as the means ± SD. Single regression analysis
was used to assess the signiﬁcance of the correlations between hor-
net venom-sIgE and rVes v 1 or rVes v 5. A P value <0.05 was
considered signiﬁcant. Statistical analysis was performed using
SPSS software (version 15.0 for Windows).
Levels of sIgE against rVes v 1 and rVes v 5weremeasured in the
participants, who were sIgE-positive for hornet venom
(4.0 ± 6.1 UA/ml; range, 0.371e25.8 UA/ml), and in the controls,
who were sIgE-negative. The mean levels of sIgE against rVes v 1
and rVes v 5 in the 27 subjects were 2.3 ± 6.6 UA/ml (range,
<0.35e33.2 UA/ml) and 17.2 ± 27.5 UA/ml (range,
<0.35e100 UA/ml), respectively. Signiﬁcantly positive correla-
tions were noted between the levels of hornet venom-sIgE against
rVes v 1 (2.3 ± 6.6 UA/ml, R ¼ 0.75, P < 0.001) and rVes v 5
(18.0 ± 28.3 UA/ml, R ¼ 0.83, P < 0.001) (Fig. 1). There were no
signiﬁcantly correlations between the severities of systemic reac-
tions or the number of Hymenoptera stings and sIgE levels against
rVes v 1 or rVes v 5. As shown in Fig. 2, 14 subjects (51.9%) were
single-positive for rVes v 5 (14.3 ± 18.6 UA/ml; range,
0.59e100 UA/ml), and 11 (40.7%) were double-positive for sIgE
against Ves v 5 (25.9 ± 38.5 UA/ml; range, 0.86e100 UA/ml)
and rVes v 1 (5.6 ± 9.6 UA/ml; range, 0.65e33.2 UA/ml). On the
other hand, 2 subjects (7.4%), who might have been sensitized to
another allergen, were double-negative for sIgE against rVes v 1
and rVes v 5. No subjects were single-positive for rVes v 1. As ex-
pected, all controls were negative for sIgE against both rVes v 1
and rVes v 5. And there were no clinical differences between single
positive for sIgE against rVer v 5 and double positive for sIgE against
rVes v 1. These results suggest the existence of two speciﬁc popula-
tions of hornet venom-sIgE-positive people in Japan: single-
positive against rVes v 5 or double-positive against rVes v 1 and
rVes v 5. Peter et al.2 reported a rate of sIgE against rVes v 5 and
rVes v 1 of 84.5% and 7.5%, respectively in 200 Vespula venom-
allergic subjects. Moreover, in a study of 308 subjects, ImmunoCAP
revealed rates of sensitization (0.35 UA/ml) of 83.4% for conven-
tional yellow jacket (Vespula vulgaris) venom, 44.2% for rVes v 1,
89.9% for rVes v 5, and 96.1% for either rVes v 1 or rVes v 5, or
both.5 In particular, in patients sensitive to yellow jacket venom,
the diagnostic sensitivity of a combination of the currently available
rVes v 5 and rVes v 1 has been reported to be as high as 92e96%,2,5,6
which is similar to our results. Compared with our data, these re-
ports of sensitization to Ves v 5 alone or to both Ves v 1 and Vesevier B.V. All rights reserved.
Fig. 1. Relationship between hornet venom-speciﬁc (s)IgE levels and rVes v 1 and rVes
v 5 in Japanese (n ¼ 27) who had experienced Hymenoptera stings. A. rVes v 1. B. rVes
v 5.
Fig. 2. Correlation between sIgE levels against rVes v 5 and sIgE levels against rVes v 1
in Japanese (n ¼ 27) who had experienced Hymenoptera stings.
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the other Vespidae venom, indicated no differences among races
and between species of Japanese Vespidae family; however, the
sensitization to Ves v 1 alone indicated the presence of differences
among races, and in Japan few individuals and the number of stings
for V. vulgaris, including species-speciﬁc Ves v 1. Our results were
considered that the measurement of sIgE against rVes v 1 was no
clinical signiﬁcance in the speciﬁc diagnosis of a Hymenoptera
venom allergy. Actually, to be clarify the clinical importance for
the measurement of sIgE against rVes v 1, it needs to analyze the
subjects who had experienced V. vulgaris stings and the subsequent
systemic reaction. In addition, the sIgE levels were higher against
rVes v 5 than against natural hornet venom, possibly because of a
reduction in Ves v 5 immunoreactivity in the extract compared
with the recombinant protein. Such a reduction might have beendue to the following: a reduced level of Ves v 5 protein in the hornet
venom extract, inefﬁcient coupling of Ves v 5 to the solid phase of
the assay, or sterical shielding of the Ves v 5 epitope by endogenous
ligands of Ves v 5 or its attachment to the solid phase. A recent
study reported that spiking conventional hornet venom with rVes
v 5 improves the sensitivity of IgE detection in patients allergic to
Vespula venom.5 rVes v 5-spiked yellow jacket venom will provide
a more reliable method for detecting hornet venom sensitization in
patients with Hymenoptera allergy.
In conclusion, 92.6% of the Japanese subjects sensitized to hor-
net venom were sIgE-positive for rVes v 5. Taken together, Ves v
5 is the most potent allergen in hornet venom, and the rVes v 5 al-
lergens should be helpful for serologically elucidating hornet
venom sensitization.
Conﬂict of interest
The authors have no conﬂict of interest to declare.
Hirokuni Hirata a,*, Naruo Yoshida a, Mineaki Watanabe a,
Kumiya Sugiyama a, Masafumi Arima b, Yoshiki Ishii a
a Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical
University, Tochigi, Japan
b Department of Developmental Genetics, Chiba University Graduate School of
Medicine, Chiba, Japan
* Corresponding author. Department of Pulmonary Medicine and Clinical
Immunology, Dokkyo Medical University, Mibu-machi, Shimotsuga-gun, Tochigi
321-0293, Japan.
E-mail address: hirokuni@dokkyomed.ac.jp (H. Hirata).References
1. Hoffman DR. Allergens in Hymenoptera venom XXIV: the amino acid sequences
of imported ﬁre ant venom allergens Sol i II, Sol i III, and Sol i IV. J Allergy Clin
Immunol 1993;91:71e8.
2. Korosec P, Valenta R, Mittermann I, Celesnik N, Silar M, Zidarn M, et al. High
sensitivity of CAP-FEIA rVes v 5 and rVes v 1 for diagnosis of Vespula venom al-
lergy. J Allergy Clin Immunol 2012;129:1406e8.
3. Sturm GJ, Bilo MB, Bonadonna P, Hemmer W, Caruso B, Bokanovic D, et al. Ves v.
5 can establish the diagnosis in patients without detectable speciﬁc IgE to wasp
venom and a possible north-south difference in Api m 1 sensitization in Europe
(reply). J Allergy Clin Immunol 2012;130:817.
Letter to the Editor / Allergology International 64 (2015) 115e117 1174. Muellar HL. Diagnosis and treatment of insect sensitivity. J Asthma Res 1966;3:
331e3.
5. Vos B, K€ohler J, Müller S, Stretz E, Ru€eff F, Jakob T. Spiking venom with rVes v 5
improves sensitivity of IgE detection in patients with allergy to Vespula venom.
J Allergy Clin Immunol 2013;131:1225e7.
6. Sturm GJ, Hemmer W, Hawranek T, Lang R, Ollert M, Spillner E, et al. Detection of
IgE to rApi m 1 and rVes v 5 is valuable but not sufﬁcient to distinguish bee from
wasp venom allergy (reply). J Allergy Clin Immunol 2011;128:247e8.
7. Tomalski MD, King TP, Miller LK. Expression of hornet genes encoding venom
allergen antigen 5 in insects. Arch Insect Biochem Physiol 1993;22:303e13.8. King TP, Lu G, Gonzalez M, Qian N, Soldatova L. Yellow jacket venom allergens,
hyaluronidase and phospholipase: sequence similarity and antigenic cross-
reactivity with their hornet and wasp homologs and possible implications for
clinical allergy. J Allergy Clin Immunol 1996;98:588e600.
Received 4 July 2014
Received in revised form 17 August 2014
Accepted 24 August 2014
Available online 18 December 2014
